According to the research report titled ‘Asia Pacific Intragastric Balloon Market Share By Filling Material, End-use, Product, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’ available with Market Study Report, Asia-Pacific intragastric balloon market is expected to surpass a valuation of USD 13 million by the year 2026.
 

Factors such as rising prevalence of obesity, increasing adoption of sedentary lifestyle and high consumption of junk food have impelled the demand for intragastric balloons, which in turn is augmenting the growth of Asia-Pacific intragastric balloon market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609886/
 

Additionally, shifting preference among patients towards minimally invasive surgical techniques due to reduced hospital stay and low blood loss is stimulating the overall market outlook. However, rising concerns regarding risks associated with intragastric balloons such as nausea and abdominal pain along with lack of reimbursement are expected to hamper the expansion of the market throughout the analysis timeframe.
 

Based on product, from the report claims that dual balloon segment is estimated to record a healthy CAGR of 33% over 2020-2026, owing to rising product demand due to its advantages such as faster weight reduction and increased patient comfort. Moreover, the availability of a second balloon as a reinforcement, in case the first balloon deflates is further fueling the growth of the segment.
 

With regards to filling material, the gas-filled segment accounted for 35% of the Asia-Pacific intragastric balloon market shares in the year 2019. Numerous advantages of the product such as reduced nauseous feeling, increased comfort, light weight, and resistance against gastric acid as well as bacteria are propelling the growth of the segment through 2026.
 

Moving on to the end-user spectrum, the ambulatory surgical centers segment reflected around 35% of the overall market share in 2019. The segment is projected to witness significant growth during 2020-2026, primarily due to factors such as rising demand for single session procedures and cost efficiency of the service.
 

Elaborating on the country-level analysis, the report states that China intragastric balloon market is predicted to exhibit a 21% CAGR over 2020-2026. High presence of skilled healthcare professionals, low costs of the procedures, and rapid development in the medical tourism sector of the country are helping China to emerge as a lucrative growth avenue for Asia-Pacific intragastric balloon market.
 

The companies that hold a strong presence in Asia-Pacific intragastric balloon market are Shandong Institute of Medical Instruments, Spatz FGIA, Inc., Silimed Inc., ReShape Lifesciences Inc., Obalon Therapeutics, Inc., Helioscopie Medical Implants, Endalis, Districlass Medical SA, Apollo Endosurgery, Inc., and Allurion Technologies Inc.